abstract: Blastocyst hatching is critical for successful implantation leading to pregnancy. Its failure causes infertility. The phenomenon of blastocyst hatching in humans is poorly understood and the available information on this stems from studies of rodents such as mice and hamsters. We and others showed that hamster blastocyst hatching is characterized by firstly blastocyst deflation followed by a dissolution of the zona pellucida (zona) and accompanied by trophectodermal projections (TEPs). We also showed that embryo-derived cathepsins (Cat) proteases, specifically Cat-L, -B and -P act as zonalysins and are responsible for hatching. In this study, we show the expression and function of one of the potential regulators of embryogenesis, cyclooxygenase (COX)-2 during blastocyst development and hatching. The expression of COX-2 mRNA and protein was observed in 8-cell through hatched blastocyst stages and it was also localized to blastocyst's TEPs. Specific COX-2 inhibitors, NS-398 and CAY-10404, inhibited blastocyst hatching; percentages achieved were only 28.4 + 5.3 and 32.3 + 5.4%, respectively, compared with .90% with untreated embryos. Interestingly, inhibitor-treated blastocysts failed to deflate, normally observed during hatching. Supplementation of prostaglandins (PGs)-E 2 or -I 2 to cultured embryos reversed the inhibitors' effect on hatching and also the deflation behavior. Importantly, the levels of mRNA and protein of Cat-L, -B and -P showed a significant reduction in the inhibitor-treated embryos compared with untreated embryos, although its mechanism remains to be examined. These data provide the first evidence that COX-2 is critical for blastocyst hatching in the golden hamster.
Introduction
During early mammalian development, the preimplantation embryo, including the blastocyst, remains encased in a protective, acellular, glycoproteinaceous coat viz, the zona pellucida (zona; ZP). Prior to implantation into the receptive uterine endometrium, the blastocyst must hatch out of the ZP (McLaren, 1970) . In most primates studied, including humans, hatching of blastocyst is driven by a hydrostatic pressure exerted by the expanded blastocyst causing a nick in the zona, which remains largely intact, post-hatching (Lopata and Hay, 1989; Seshagiri and Hearn, 1993) .This hatching behavior is observed also in most other species such as the mouse (Bergstrom, 1972) , rat (Surani, 1975) and the cow (Massip and Mulnard, 1980) . In hamsters, however, the blastocyst initially expands, followed by a very conspicuous deflation and then it hatches with a complete dissolution of the zona (Kane and Bavister, 1988a, b; Mishra and Seshagiri, 1998) . Moreover, the hatching blastocyst invariably exhibits extensive trophectodermal projections (TEPs) having functional significance in the hatching and implantation phenomenon (Gonzales et al., 1996a, b; Sireesha et al., 2008; Seshagiri et al., 2009) . In this regard, the golden hamster offers a unique paradigm for studying the phenomenon of mammalian blastocyst hatching.
Blastocyst hatching is shown to be a protease-driven phenomenon involving zonalytic enzymes, i.e. serine protease such as 'strypsin' in the mouse (Perona and Wassarman, 1986) while cysteine proteases, belonging to the cathepsin (Cat-) class, i.e. Cat-L, -B and -P, are shown in the hamster (Mishra and Seshagiri, 2000a; Sireesha et al., 2008) . In the hamster, the hatching event is governed by an extremely complicated but cooperative interplay of various cellular (Gonzales et al., 1996a, b) and molecular regulators (Seshagiri et al., 2002 (Seshagiri et al., , 2009 ). Among other potential regulators of mammalian hatching, cyclooxygenase-2 (COX-2)-generated prostaglandins (PGs) and their signaling systems have emerged as potential modulators of peri-hatching development in many species such as the mouse (Chan, 1991; Huang et al., 2004 Huang et al., , 2007 Tan et al., 2005; Pakrasi and Jain, 2007; Kang et al., 2011) , rat (Parr et al., 1988; Braissant and Wahli, 1998) , skunk (Das et al., 1999) , rabbit (Dey et al., 1980) , sheep (Liszewska et al., 2009) , pig (Kim et al., 2010) and also in the human (Wang et al., 2002) . Additionally, COX-2-generated PGs are shown to be important in a number of reproductive processes, in particular, for embryo implantation (Achache et al., 2010; Salazar et al., 2010) and for spacing of embryos in the uterus (Lim et al., 1999; Ye et al., 2005) . The COX-2 knock-out mice show early developmental defects (Dinchuk et al., 1995; Lim et al., 1997) and exogenous treatment with PGE 2 of mutant mice is capable of rescuing the defects (Davis et al., 1999) . However, it is unclear whether the hatching failure contributes to pregnancy loss observed in these mutant mice.
Despite this substantial information on the importance of COX-2 and its eicosanoids in reproductive-development processes, knowledge is limited on its role on blastocyst development, specifically hatching. It is not clear as to which prostanoids primarily drive blastocyst formation and its hatching. This information is particularly lacking in the human and in the hamster. Importantly, it is not known whether or not COX-2-mediated signaling events regulate hatching-associated protease production in any mammalian embryos, even though such a role is established in tumor cell metastasis (Wang et al., 2007) . This is notwithstanding the fact that hatching-related deficiencies account for a major cause of human infertility and they have impact on human infertility-management efforts (Ruan et al., 2011) . Hence, in this study, we assessed the functional significance of COX-2 and PGs in peri-hatching embryo development focusing specifically on the hatching phenomenon in the golden hamster.
Material and Methods

Animals
Sexually mature golden hamsters (Mesocricetus auratus) were maintained on a 14 h light:10 h dark lighting schedule at ambient temperatures and provided with pelleted feed and water ad libitum. Six-to 8-week-old female hamsters were used as embryo donors. Females were mated overnight with proved stud males. The following day, vaginal smears were checked for the presence of sperm and assigned as Day 1 of pregnancy. The Institutional Animal Ethics Committee approved procedures for animal handling and experimentation, in accordance with the Guidelines on Use of Laboratory Animals for Research (INSA, New Delhi).
Recovery and culture of embryos
Female hamsters were superovulated with an i.p. injection of 30 IU pregnant mares' serum gonadotrophin on the day of post-estrous discharge and mated 3 days later. In the evening of Day 3 of pregnancy, in vivo developed 8-cell embryos were collected by flushing the excised uterine horns with 0.5 ml of equilibrated HECM-2 m (Mishra and Seshagiri, 1998) . Well-formed, noncompact 8-cell embryos were used for all experiments. At least five embryos from the same donor were cultured for each treatment group and experiments were repeated at least three times with different embryo donors. Embryos were cultured in 50 ml of HECM-2 h in the absence or presence of COX-2 inhibitors, NS-398 or CAY-10404, or PGE 2 or Iloprost, at 378C in an atmosphere of 5% CO 2 in air and monitored microscopically every 12 h for a total of 72 h for development and hatching.
Upon culture of embryos in the presence or absence of inhibitors for mentioned durations, embryos were scored for hatching. Blastocysts with lysed zonae were considered hatched and their percentages out of total embryos cultured determined Seshagiri, 1998, 2000a, b) . Embryos (diameter: 50 mm) with no clearly visible blastocoel and with a prominent peri-vitelline space were scored as deflated embryos. Embryos (diameter: 100 mm) with expanded blastocoel with no visible peri-vitelline space were scored as inflated embryos. Embryo diameters were measured by first capturing their images using a CCD camera and then subjecting them to Image Pro Plus software program.
Embryonic mRNA isolation, real-time PCR analysis
Embryos at different stages were either stored at 2708C for RNA isolation or fixed in 4% paraformaldehyde (PFA) for immunostaining purposes. All reagents were procured from Sigma (St Louis, MO, USA) unless specified otherwise. Embryonic mRNA was isolated from pooled embryos (n ≥ 20) using Dyna beads-Oligo dT25 (Dynal Biotech, Oslo, Norway) according to the manufacturer's instructions. The isolated mRNA was reverse transcribed in 20 ml of reaction mixture with MMLV reverse transcriptase (Fermentas, now a part of Thermo Scientific, Ontario, Canada). Water blanks were used for negative controls. One embryo equivalent cDNA were used in a final volume of 20 ml for both RT-PCR and qPCR reactions; qPCR reactions were carried out using a SYBR green qPCR Mastermix and real-time PCR detection system according to the manufacturer's instructions (Applied Biosystems, USA). The b-actin gene was used as an internal control. Primers used for hamster Cat-L were: F:
Three identical real-time qPCR assays were performed, and in each assay, the transcript levels of each of the zonalytic protease genes were measured in duplicate. For the mathematical analysis, Ct value for each transcript was determined. The relative quantification of gene expression was analyzed by the 2 2DDCt method (Livak and Schmittgen, 2001 ).
Indirect immunocytochemistry, nuclear staining and protein quantification
For immunocytochemical analysis, different embryonic stages of hamster embryos were fixed for 30 min at room temperature in 4% fresh PFA (pH 7.4) in phosphate-buffered saline (PBS). Fixed embryos were washed in PBS-poly vinyl alcohol (PVA), permeabilized with 0.2% Triton X-100 for 30 min and blocked in 3% bovine serum albumin for 2 h at room temperature. Embryos were incubated with goat-anti-COX-2 polyclonal antibody (SC-1745, Santacruz Biotech., Santacruz, CA, USA), monoclonal anti-Cat-L antibody (Serotec Ltd, Oxford, UK) or polyclonal anti-Cat-P antibody (Mason et al., 2004; Hassanein et al., 2007; Sireesha et al., 2008) . All primary antibodies were used at 1:100 dilutions in blocking solution overnight at 48C. Control embryos were treated with appropriate non-immune IgG which acted as negative controls. After thorough washing in PBS-PVA, embryos were incubated in anti-goat Cy-5 (for COX-2), anti-mouse or rabbit-FITC (for Cat-L and -P, respectively) for 1 h. For quantification of protein levels of Cat-L and -P, embryos from control and inhibitor-treated groups were processed as detailed above and their relative Cat-L and -P protein levels were measured using LSM-softwarew of the Zeiss LSM laser-scanning confocal microscope (Carl Zeiss Microimaging, GmBH, Germany). TEPs were stained with phalloidin-FITC. Nuclear staining was accomplished by slightly modifying an earlier procedure used by Seshagiri and Bavister (1990) by incubating embryos in 100 mg/ml RNAse (Fermentas, Ontario, Canada) for 15 min followed by incubation in 0.05 mg/ml Propidium Iodide for 30 min. All embryos were appropriately washed and mounted using Vectashield anti-fade solution (Vector Laboratories, Burlingame, CA, USA) and viewed under Carl Zeiss LSM Meta laser-scanning confocal microscope (Carl Zeiss Microimaging) for fluorescence signal.
Arbor, MI, USA). COX-2-inhibition rescue experiments were performed with PGE 2 (P5640, Sigma, St Louis, MO, USA) and Iloprost, a secondgeneration structural analog of Prostacyclin, PGI 2 (Cayman Chem.). Both inhibitors and PGE 2 (Sigma, St Louis, MO, USA) were dissolved in dimethylsulphoxide (DMSO) (Sigma, St Louis, MO , USA). In control experiments, embryos were treated with similar concentrations of appropriate diluents. Freshly recovered 8-cell embryos or in vitro developed early blastocysts were cultured continuously in HECM-2 h for 72 or 48 h, respectively, without or with NS-398 or CAY-10404 (25, 50, 75 mM) . Rescue experiments were performed with both PGE 2 and Iloprost (0.1, 1, 10 mM). Inhibition experiments were tested on freshly recovered 8-cell embryos or early blastocysts, continuously for 72 h or 48 h, respectively. The experimental strategy for COX-2 inhibition and PG-supplementation is depicted in Fig. 1 .
All embryos were monitored for viability, gross-morphology and hatching. The viability of the inhibitor-treated embryos was monitored by 0.5% Trypan-blue staining. After staining, the number of cells that had taken up the dye and unstained cells were judged in each blastocyst and those with about ≤10% blue staining were considered viable. Mean number of cells (MNCs) was calculated as total number of cells in embryos subjected to a particular treatment, divided by total number of embryos scored. Trophoblasts' outgrowths of post-hatched blastocysts were also assessed. Briefly, hatched blastocysts were placed on serum-coated dishes and their attachments and outgrowths of monolayers of trophoblasts were monitored by capturing images using a CCD camera and Image Pro Plus software program, as described elsewhere (Mishra and Seshagiri, 1998; Sireesha et al., 2008) .
Statistical analysis
For all experiments, the mean values were calculated from the total number of embryos cultured during a particular treatment. A block design was employed to control between animal variations. One replicate experiment consisted of freshly recovered 8-cell embryos from individual female donors, randomly distributed and in similar numbers in all treatments. A minimum of three replicate experiments (from three different animals) was performed under identical experimental conditions. To assess statistical significance of treatment effects, one-way analysis of variance (one-way ANOVA), followed by Tukey post hoc test was performed to obtain P-values and adequately compare all treatment pairs (Graph Pad Prism Software Version-5, CA, USA).
Results
Expression of COX-2 in hamster preimplantation embryos
Hamster peri-hatching embryonic stages were assessed for the expression of COX-2 transcripts. COX-2 m-RNA was detected in the 8-cell embryo, morula, blastocyst and hatched blastocyst stages ( Fig. 2A) . Similarly, in these stages, the expression of COX-2 protein, using anti-COX-2 antibodies, was also observed. Immunostaining was found to be cytoplasmic and uniformly distributed both in the inner cell mass (ICM) and trophoectoderm (TE) cells of the blastocyst (Fig. 2B) . However, immunostaining of COX-2 was negligible in oocyte, 1-cell, 2-cell and 4-cell stages of embryos (data not shown). Interestingly, in peri-hatching blastocysts, COX-2 localization was found to be predominantly sequestered to the TE cells ( Fig. 2Bd) and it was particularly enriched in the actin-based dynamic TEPs, associated with the hatching blastocyst ( Fig. 2C ). Besides, we consistently observed a predominant appearance of TEPs at the abembryonic pole of the deflated blastocyst (unpublished data).
Functional role of COX-2 on blastocyst hatching
Influence of COX-2 inhibitors on hatching
In order to assess the influence of COX-2 on blastocyst hatching, we tested the effect of two isoform-specific inhibitors of COX-2, viz., NS-398 and CAY-10404. Inhibitors were tested on freshly recovered 8-cell embryos or early blastocysts, continuously for 72 or 48 h, Cyclooxygenase-2 in blastocyst hatching respectively. As observed previously, when 8-cell embryos were cultured in hatching-supporting medium (HECM-2 h; Mishra and Seshagiri, 1998) , they cavitated and formed robust blastocysts which conspicuously deflated and caused focal lysis of the zona followed by global zona dissolution leading to embryonic hatching (Mishra and Seshagiri, 1998; Sireesha et al., 2008) . Eight-cell embryos or early blastocysts cultured in inhibitor-free conditions showed almost total hatching. In contrast, NS-398 and CAY-10404 used in increasing concentrations of 25, 50 and 75 mM, inhibited hatching in a dose-dependent manner. While 95.6 + 3% of 8-cell embryos cultured continuously for 72 h in the vehicle-control hatched, the inhibitor-treated embryos showed reduced hatching rates and percentages observed were 66.2 + 6.1, 35.2 + 5 and 28.4 + 5.3% for 25, 50 and 75 mM concentrations of NS-398, respectively (Fig. 3Ai) . Similarly, with early blastocysts cultured for 48 h, percentages observed were 80 + 2.7 and 55.7 + 3% for 50 and 75 mM concentrations, respectively; while the untreated-control embryos showed 97.1 + 2.9% hatching rates (Fig. 3Biii) . Similarly, while 98.1 + 2% of 8-cell embryos, cultured continuously for 72 h in the vehicle-control, hatched, CAY-10404-treated embryos showed reduced hatching rates and the percentages observed were 81.2 + 4.1, 49.7 + 4.6 and 32.3 + 5.4% for 25, 50 and 75 mM concentrations, respectively (Fig. 3Aii) . Similarly, with early blastocysts, cultured for 48 h, percentages observed were 77.4 + 2.6 and 51.8 + 1.7% in 50 and 75 mM CAY-10404, respectively, compared with 96.4 + 3.6% with the untreated-control embryos (Fig. 3Biv) . Interestingly, when embryos were treated with either of the specific COX-2 inhibitors, they exhibited marked inflation prior to hatching (Fig. 4i) ; also, see Section 'COX-2 inhibitors cause hatching of hamster blastocysts in an inflated state, which is partially rescued by PG addition').
Assessment of mean diameter, mean cell numbers and embryo viability during hatching
To assess embryonic integrity and viability of inhibitor-treated embryos, we measured their mean diameters (post-60 h) either in the presence or absence of the inhibitors. The diameter of peri-hatching embryos in the control-drop, post-60 h in culture, measured 52.5 + 2.0 mm, whereas embryos cultured in the 75 mM NS-398 drop measured 98.5 + 3.0 mm and those in 75 mM CAY-10404 were 96.7 + 3.9 mm across (Fig. 4iiA) . In order to ascertain whether the observed inflation phenotype was as a consequence of possible increase in the MNC of an embryo, we determined MNCs in all control and treated embryos. The control embryos had a MNC of 24.1 + 0.53, whereas NS-398 and CAY-10404-treated embryos had 24.3 + 0.8 and 25.8 + 0.67, respectively (Fig. 4iiB) . Hence, our results show that MNCs were similar in embryos under vehicle and inhibitor-treatment groups, despite their diameters being vastly different.
Moreover, embryos which successfully hatched were monitored for viability using 0.5% trypan-blue staining. About 3.1 + 0.5, 2.8 + 0.6 and 4.2 + 1.3 cells took up the trypan-stain in vehicle-control, 75 mM NS-398 and CAY-10404-treated groups, respectively, while the positive control embryos showed 94.5 + 1.0 (Fig. 4iiC) . Lastly, the viability of hatched blastocysts, cultured without or with inhibitors, was also assessed using the TB-attachment assay. Results showed morphological features of the outgrowth of inhibitor-treated embryos, at 24 and 60 h time points, which was similar to that in control embryos (data not shown). 
Rescue of COX-2 inhibitor-mediated inhibition of hatching by PG supplementation
Because PGs act as downstream effectors of COX-2 action, it was considered that its supplementation could rescue the inhibition of hatching brought about by COX-2 inhibitors. In order to test this, we added PGE 2 and Iloprost (structural analog of PGI 2 ) to cultured embryos treated with COX-2 inhibitors (NS-398 and CAY-10404). NS-398-mediated inhibition of blastocyst hatching (34.6 + 2%) was overcome by the addition of PGE 2 and the percentages of blastocyst hatching achieved in PGE 2 treatments were 40.2 + 3.5, 58.7 + 3 and 84.6+ 1.8% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 5Ai) . Similarly, CAY-10404-mediated inhibition of blastocyst hatching (38.3 + 4.4%) was also overcome by the addition of PGE 2 and the percentages of blastocyst hatching achieved were 55.6 + 3.3, 76.04 + 4.7 and 85.2 + 2.2% for 0.1, 1.0 and 10 mM PGE 2 concentrations, respectively (Fig. 5Aii) . Cyclooxygenase-2 in blastocyst hatching When Iloprost was tested, instead of PGE 2 , the NS-398-mediated inhibition (32 + 1.2%) was also reversed, and the percentages of blastocyst development achieved were 39.1 + 5, 48.6 + 1.4 and 64.2 + 2.4% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 5Biii) . Similar was the observation made with CAY-10404-mediated inhibition of treated embryos (33 + 2%) as well. The percentage of blastocyst hatching in Iloprost-treated groups achieved were 35 + 2.2, 46.7 + 4.6 and 62 + 2% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 5Biv) . Overall, we observed that PGE 2 was more effective than PGI 2 in overcoming the effects of COX-2 inhibition (Supplementalry data, Fig. S1 ).
COX-2 inhibitors cause hatching of hamster blastocysts in an inflated state, which is partially rescued by PG addition COX-2-inhibitor-treated embryos demonstrated extremely interesting hatching behavior. When embryos were treated with either of the specific COX-2 inhibitors from 8-cell stage for 72 h, they exhibited marked inflation prior to hatching (Fig. 6A) , which was retained post-hatching for several hours (Fig. 6B, asterisk) : Large number of embryos that hatched left behind intact zonae in cultures (Fig. 6B, star) . This was quite unlike the hatching behavior normally observed with embryos in vehicle-treated (or untreated) controls, i.e. embryos hatching in a deflated state with global zona dissolution. 
Interestingly, NS-398 and CAY-10404 used in concentrations of 25, 50 and 75 mM, promoted the inflated-hatching phenotype in a dosedependent manner. While only 3.4 + 1.7% of freshly isolated 8-cell embryos cultured continuously for 72 h in the vehicle-control hatched in an inflated state, inhibitor-treated embryos showed increased hatching in an inflated state and percentages observed were 32.3 + 2.1, 54.1 + 7.5 and 80.2 + 8% for 25, 50 and 75 mM concentrations of NS-398, respectively (Fig. 7Ai) . Similarly, with early blastocyst stage cultured for 48 h, 37.8 + 2.5 and 46 + 2.4% hatched in an inflated state in the 50 and 75 mM NS-398, respectively, as against 6.7 + 2.7% of the control embryos (Fig. 7Biii ). Similar observations were made when CAY-10404 was used continuously in culture for 72 h, where 31.6 + 3.6, 55.8 + 6 and 80.53 + 9% embryos hatched in an inflated state in the 25, 50 and 75 mM treatments, respectively, when compared with 6.8 + 3.2% of the vehicle-treated embryos (Fig. 7Aii) . Early blastocysts cultured in the presence of 50 and 75 mM of CAY-10404 for 48 h, showed 32.7 + 4.5 and 43.3 + 4.1% hatching in an inflated state as against only 5.6 + 3.3% of embryos hatching in the vehicle-control group (Fig. 7Biv) .
NS-398-mediated inflation of blastocysts prior to hatching (75 + 8.3%) was partially overcome by the addition of PGE 2 and the percentages of blastocyst hatching in an inflated state in PGE 2 treatments were reduced to 45.8 + 4.2, 31.6 + 4.2 and 30.5 + 3.3% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 8Ai) . Similarly, CAY-10404-mediated inflation of blastocysts prior to hatching (73 + 10.4%) was also partially overcome by the addition of PGE 2 and the percentages of blastocyst hatching in an inflated state were reduced to 40 + 10, 33 + 5.7 and 24 + 2% for 0.1, 1.0 and 10 mM PGE 2 concentrations, respectively (Fig. 8Aii ). When Iloprost was tested instead of PGE 2 , the NS-398-mediated inflation of blastocysts prior to hatching (79.1 + 12.5%) was also reversed, although to a lesser degree than PGE 2, and the percentages of blastocyst hatching in an inflated state in Iloprost treatments were reduced to 54.1 + 4.2, 37.5 + 4.2 and 33.3 + 6% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 8Biii) . Similar were the observations made with CAY-10404-mediated inflation of blastocysts prior to hatching (73.3 + 11.3%). The percentages of blastocyst hatching in an inflated state in the Iloprost treatment group were reduced to 53.3 + 3.3, 30 + 8.1 and 33.3 + 4.5% for 0.1, 1.0 and 10 mM concentrations, respectively (Fig. 8Biv) .
Transcript quantification of embryonic zonalytic proteases, following treatment of embryos with COX-2 inhibitors
We used real-time RT-PCR to quantify transcripts of Cat-L, -B and -P enzymes in 72 h cultured embryos treated with COX-2 inhibitors. Three identical real-time qPCR assays were performed, and in each assay the transcript levels of the zonalytic protease genes were measured in duplicate. We found that the mRNA levels of all the three proteases were markedly down-regulated in the NS-398-and CAY-10404-treated embryos, when compared with vehicle controls. We observed a reduction of 60 and 51% in the levels of the Cat-L transcript for NS-398 and CAY-10404 treatments, respectively, when compared with the controls (Fig. 9Ai) . Similarly, compared with controls, Cat-B transcript levels were reduced by 70 and 58% when treated by NS-398 and CAY-10404, respectively (Fig. 9Aii) . The Cat-P transcript was also down-regulated by 80% in the NS-398 and 58% in the CAY-10404 treatments (Fig. 9Aiii) .
Quantitative-analysis of immunolocalization data of cathepsins revealed differential protein levels of Cat-L and -P in control and inhibitor-treated embryos. Figure 9B shows representative images of embryos stained for Cat-L (Fig. 9Bi ) and -P (Fig. 9Bii) . Strong immunofluorescence signal for Cat-L and -P was obtained with embryos cultured under vehicle conditions (Fig. 9Bia, iia) . Embryos cultured in the presence of NS-398 and CAY-10404 gave comparatively weaker signal for Cat-L ( Fig. 9Bic and e) and -P (Fig. 9Biic and e) . Mean immunofluorescence intensity quantification revealed that, indeed, the levels of both proteases were reduced under conditions of COX-2 inhibition as against vehicletreated controls. Cat-L immunofluorescence showed a mean intensity of 60.5 + 3.8 in the untreated controls, while the levels were 35.5 + 1.9 and 32.2 + 2.6 in 75 mM NS-398 and CAY-10404, respectively (Fig. 9Ci) . Similar results were obtained with Cat-P immunofluorescence quantification experiments. Untreated control embryos showed a mean fluorescence intensity of 81.2 + 3, while the levels were significantly decreased to 37.1 + 1.5 and 36.6 + 2.1 in the 75 mM concentration of NS-398 and CAY-10404 treatments, respectively (Fig. 9Cii) . The Cyclooxygenase-2 in blastocyst hatching observed decreases in protein levels of both proteases, verified the reduced levels of their respective transcripts observed in the qPCR experiments.
Discussion
The highlight of the present investigation is that the COX-2, via its production of prostanoids, plays a critical role in blastocyst hatching in the golden hamster. The embryonic expression of COX-2 (mRNA and protein) is observed during peri-hatching blastocyst stages and it is intimately localized to the hatching event-associated TEPs. The two contemporary second-generation COX-2-selective inhibitors NS-398 and CAY-10404 inhibit blastocyst hatching, which could be reversed by exogenous supplementation of prostanoids. Importantly, the COX-2-inhibitor-mediated inhibition of hatching is accompanied by a significant reduction in the embryonic expression of Cat-L, -B and -P.
Our observation on the specific inhibition of hatching, by COX-2 inhibitors, emphasizes the critical importance of COX-2 as one of the major regulators of peri-hatching development. Our data are in agreement with other reports on mice (Huang et al., 2004; Pakrasi and Jain, 2007) and cattle (Song et al., 2009 ) blastocyst hatching. We indeed have shown the need for COX-2 for successful hatching, in a restricted spatiotemporal hatching window by testing at two different time points, unlike studies in the mouse (Wang et al., 2004) . Our results indicate that the COX-2 mediated signaling events are more pronounced in 8-cell embryos than in early blastocysts. Besides, the COX-2-dependent molecular and cellular processes are required for blastocyst morphogenesis and hatching. We believe that these effects may have initiated prior to compaction and cavitation of the developing embryos. Our results on the embryonic viability and trophoblast attachment assays indicate that COX-2 inhibition specifically affects the hatching process per se and its manifestation is not as a consequence of loss of embryonic viability.
The reversal of hatching inhibition by supplementation of PGE 2 and PGI 2 in COX-2 inhibitor-treated embryos shows that COX-2-derived prostanoids are indeed responsible for the observed effects on hatching. Additionally, the fact that PGE 2 is superior to PGI 2 in augmenting blastocyst hatching in inhibitor-treated embryos indicates that PGE 2 may be the key prostanoid mediator, required for embryo hatching. Also, PGI 2 is considered essential for hatching and implantation (Lim et al., 1999; Huang et al., 2004; Liu et al., 2006) . Of relevance here is the report that PGE 2 , but not PGI 2 , is the major PG at implantation sites in the hamster uterus (Wang et al., 2004) . Incidentally, PGE 2 /I 2 addition to cultured embryos did not augment hatching rates (data not shown), indicating that its production is necessary for rendering embryos hatching-competent but not adequate for inducing hatching. It is also possible that since we routinely achieve almost 100% hatching in our indigenously developed HECM-2 h medium (Mishra and Seshagiri, 1998; Sireesha et al., 2008) , we are unlikely to demonstrate any augmentation in the hatching rate in the inhibitor-free cultures. Contrastingly, in the mouse, augmentation following inhibitor treatment was possible due relatively to inferior blastocyst hatching rates normally observed in this species (Huang et al., 2004) .
We have earlier shown that cathepsin-proteases, especially Cat-L, -B, -P are critically required to bring about zona-lysis in hamsters (Sireesha et al., 2008) . In this study, our findings on the markedly reduced embryonic expression of Cat-enzymes correlated with reduced hatching rates in the COX-2-inhibitor-treated embryos. Consequently, embryos that hatched in the presence of the inhibitor left behind intact, non-lysed zonae in cultures (Fig. 6) , in contrast to control embryos which normally showed a characteristic global zona dissolution during hatching (Mishra and Seshagiri, 1998) . Our data show that inhibition of COX-2, indeed, effectively down-regulated mRNA expression levels of Cat-L, -B and -P and their decreased intra-embryonic protein levels. These results show that COX-2-mediated signaling components directly and effectively modulate hamster zona-hatching development via a transcriptional inhibition of expression of zonalytic proteases.
One of the exciting observations made in the study is the peripheral sequestration and intense enrichment of COX-2, in the TEPs which also harbor zonalytic proteases, i.e. Cat-L, -B and -P (Sireesha et al., 2008) . It is known that TEPs are developmentally associated with hatching blastocysts (Blandau and Rumery, 1957; Gonzales et al., 1996a, b) and our circumstantial evidence point to the fact that they would be integral cellular components functionally critical for mammalian blastocyst hatching. Interestingly, similar cellular entities are reported in mouse blastocysts (McRae and Church, 1990; Salas-Vidal and Lomeli, 2004) but their role in hatching remains to be investigated. In the human, even though cellular projections between the ICM and the TE cell types have been demonstrated by ultra-structural studies (Ducibella et al., 1975; Salas-Vidal and Lomeli, 2004; Hardarson et al., 2012) , their biological significance in the context of hatching remains virtually unexamined, despite the fact that hatching failure is believed to be the major cause of pregnancy failure in ART.
It is interesting to note for the first time that COX-2 inhibitor-treated blastocysts hatched in inflated state, with the absence of peri-vitelline space (Fig. 6 ). This is unlike the profound deflation normally associated with untreated-blastocysts during hatching (Kane and Bavister, 1988a, b; Gonzales et al., 1996a; Mishra and Seshagiri, 1998) . This hatching behavior is in contrast to the morphological-behavior of mouse blastocysts during their hatching under similar conditions of PG-deprivation, wherein they fail to inflate prior to hatching (Biggers et al., 1978) . This apparent inhibitor-dose-dependent behavior and the partial reversal of hatching phenotype upon PG-addition in our study could be largely attributed to the lack of COX-2-generated signaling events. Besides, this, in part, could be explained due to persistence of blastocoel, reflected by increased embryonic diameters which could exert hydrostatic pressure on the ZP, thereby rupturing it and, aided/driven by limitedly available zonalytic Cat-enzymes in the inhibitor-treated embryos. Since cell numbers in the vehicle-and inhibitor-treated blastocysts (Fig. 4) did not show any differences, we speculate that the observed inflation of blastocysts could be a fall out of dys-regulation of vectorial fluid-flux in blastocysts, as a consequence of the lack of COX-2-derived-eicosanoids in the inhibitor-treated conditions. Drawing parallels, the observed functionality of TEPs-bearing TE cells is comparable with kidney capsule epithelial cells, in terms of ions and water transport characteristics in the two types of epithelial cells. Indeed, the blastocyst formation itself is tightly coupled to the development of trans-trophectoderm ion-transport systems, including the Na-K ATPase and aquaporin modules (Watson and Barcroft, 2001 ). The COX-2 inhibition experiments and the partial rescue of inflation observed with PG-supplementation in our study points to the possibility that prostanoid signaling, especially those mediated by PGE 2 , could regulate trans-TE fluid movement in hamster-blastocysts, analogous to the ion-transport mechanisms operating in the kidney capsule epithelial cells (Matlhagela and Taub, 2006; Lauridsen et al., 2010) . This premise is substantiated by the fact that the COX-2 null mice exhibit severe renal fluid and electrolytes transport abnormalities (Dinchuk et al., 1995) .
Another exciting finding is the consistent and the predominantly polarized appearance of TEPs at the abembryonic pole of the hamster blastocyst. Additionally, we observed the localization of several signaling molecules including estrogen receptor-a and the Flotillin-positive lipid-rafts markers at the abembryonic side of TEPs (Seshagiri et al., 2009; unpublished data) . It is indeed remarkable that the hamster blastocyst at the abembryonic pole harbors most of the key hatching-enabling functionally active molecular factors. Because, the abembryonic pole of the blastocyst opposes and adheres to the implantation site of the uterine epithelium in hamsters, unlike in non-human primates (Lee and DeMayo, 2004) , there is a possibility that the two sequential events, i.e. hatching and implantation are critically and functionally linked in tandem. This is borne out by the fact that the abembryonic pole-TEPs, with the associated expressions of hatching and possibly implantation-initiating molecules, are sequential in appearance and they appear to share for both events. All occurring in a tightly controlled spatio-temporal manner, they could be critical for the establishment of early pregnancy in this species. Similarly, it could be extrapolated in humans and other rodent species having similar developmental phenomenon pertaining to hatching and implantation (Schlafke and Enders, 1975; Gonzales et al., 1996b; Seshagiri et al., 2009) . Although direct evidence is lacking, our exciting observations made in the hamster blastocyst hatching, may provide new insights into our understanding of the early establishment of human pregnancy.
In conclusion, our studies demonstrate, for the first time, that COX-2 protein is expressed in the peri-hatching blastocysts and that the COX-2-derived prostanoids, importantly, PGE 2 play a critical role in the morphogenesis and hatching of blastocysts in the hamster. We demonstrate that COX-2 modulates hatching via its regulation of zonalytic cathepsins (Cat-L, -B and-P) and these key events occur rather exclusively in TEPs at the abembryonic pole of the blastocyst. These observations provide new insights into the critical role of COX-2 and its derived prostanoids signaling systems play in hatching phenomenon in addition to their known function in early developmental events including implantation. These findings have immense clinical significance in the context of our understanding of blastocyst hatching behavior and its possible failures, encountered in human female infertility.
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